Glycoconjugate vaccine strategies for protection against invasive Salmonella infections. - Wikidata - wikimedia - TriplyDB

Glycoconjugate vaccine strategies for protection against invasive Salmonella infections.

Glycoconjugate vaccine strategies for protection against invasive Salmonella infections.

http://www.wikidata.org/entity/Q36184367

about

Vaccines against invasive Salmonella disease: current status and future directions Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens Complex adaptive immunity to enteric fevers in humans: lessons learned and the path forward Salmonella Serogroup C: Current Status of Vaccines and Why They Are Needed From Immunologically Archaic to Neoteric Glycovaccines.Development of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan Africa.Sequential acquisition of T cells and antibodies to nontyphoidal Salmonella in Malawian children Sustained protection in mice immunized with fractional doses of Salmonella Enteritidis core and O polysaccharide-flagellin glycoconjugates.Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.Strain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines against Invasive Nontyphoidal Salmonella Disease Modeling the Potential for Vaccination to Diminish the Burden of Invasive Non-typhoidal Salmonella Disease in Young Children in Mali, West Africa.Toll-Like Receptor Activation by Generalized Modules for Membrane Antigens from Lipid A Mutants of Salmonella enterica Serovars Typhimurium and Enteritidis.Evaluation of the Immunogenicity of Diphtheria Toxoid Conjugated to Salmonella Typhimurium-Derived OPS in a Mouse Model: A Potential Vaccine Candidate Against Salmonellosis Recombinant attenuated Salmonella Typhimurium with heterologous expression of the Salmonella Choleraesuis O-polysaccharide: high immunogenicity and protection.Conformational Preference of Serogroup B Salmonella O Polysaccharide in Presence and Absence of the Monoclonal Antibody Se155-4.Insights from natural infection-derived immunity to cholera instruct vaccine efforts.Two Novel Salmonella Bivalent Vaccines Confer Dual Protection against Two Salmonella Serovars in Mice.O-Serotype Conversion in Salmonella Typhimurium Induces Protective Immune Responses against Invasive Non-Typhoidal Salmonella Infections.Development of a synthetic Vi polysaccharide vaccine for typhoid fever.Immunogenicity and efficacy following sequential parenterally-administered doses of Salmonella Enteritidis COPS:FliC glycoconjugates in infant and adult mice.

P2860

Q27007088-E01F6D01-7364-4900-9C0C-E7125225D93C Q27011190-DA9F71DD-C2FE-415E-A996-C892620B6A3C Q27694492-EE621388-091C-4361-BF9F-019BBBDCDBD9 Q28388835-CD970F5A-3650-4C75-8285-E40524BF8E84 Q30238724-AA530AB1-6D74-46AF-B033-EAA27D89CE46 Q33579987-27FCC48A-2F73-4ECC-8C9E-5CE4FBA3ACE5 Q33745704-75580BCD-D938-494E-90DE-369F12C5F062 Q34760675-1C7B9B82-2C66-41F2-BC39-04A78ECBBE29 Q35887055-5010F66F-2F0F-4762-853A-F8DEA9623F80 Q36131886-A2FF586F-9A38-4666-936C-9BABFB2CFFD5 Q36275289-6920803F-4A5A-44C7-8FD7-0D59605A3E92 Q36764359-1A54B45E-C1BA-499C-9EA7-22AFBD009BA8 Q37263373-3719C999-0CE2-4D9E-B41B-3A02E448A524 Q40114957-54A4A07A-3421-4725-B1E8-1213333DE402 Q40245116-6E779A5F-5668-48C6-88FE-BCE0787C6B9E Q41426133-5048B207-9DF3-4DB2-B22E-990A32F53EB1 Q41475755-5905164F-BF63-44C3-AF79-F1ADEF361EBA Q47103827-3DB26F80-CB4B-4513-A860-F0085C9F7361 Q49914721-B92E0263-C439-4C25-A9B6-63DC2035F763 Q54201279-81A145C1-2FC9-47D2-81E5-465E41063FFA

P2860

Glycoconjugate vaccine strategies for protection against invasive Salmonella infections.

http://www.wikidata.org/entity/Q36184367

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Glycoconjugate vaccine strategies for protection against invasive Salmonella infections.

@ast

Glycoconjugate vaccine strategies for protection against invasive Salmonella infections.

@en

type

label

Glycoconjugate vaccine strategies for protection against invasive Salmonella infections.

@ast

Glycoconjugate vaccine strategies for protection against invasive Salmonella infections.

@en

prefLabel

Glycoconjugate vaccine strategies for protection against invasive Salmonella infections.

@ast

Glycoconjugate vaccine strategies for protection against invasive Salmonella infections.

@en

P1433

Q36184367-3AA71B91-7BF3-46FC-A765-9DC797F59991

P1476

Q36184367-68A121B4-CDD1-4EF9-8281-DDF821D022AB

P2093

Q36184367-6C0B85C3-BB0B-4FBB-AC00-062D848CC578

P2860

Q36184367-0545DE87-FA64-47B4-BE29-23532A2BDA27

Q36184367-0E704CF7-EDE7-4387-9196-7CA3D3EBE5B7

Q36184367-11CE6C05-547D-4ABC-9BA7-77D1D1DE3511

Q36184367-15928481-00B0-4012-B68B-7452650520CA

Q36184367-159F8892-7AF4-4BCE-8A03-F149BBEB0C43

Q36184367-1685AFFA-81AF-437F-8EFB-A2417338F704

Q36184367-16B4ED29-1B87-4382-85C1-38B22639C6E8

Q36184367-16C80F23-71ED-4AA1-A220-1B3E3E4E4A34

Q36184367-19D70967-40B5-4D6C-B2DF-B38C2134F8E6

Q36184367-1C5EDED5-6229-418E-B856-F8F8E523E8F5

P304

Q36184367-89E31B9B-C163-4B66-BBE1-C6AD12FE3219

P31

Q36184367-E7B70A58-E590-4E5F-831F-347FB7D1B755

P356

Q36184367-70E462AA-9EC4-47C1-9F13-D4BE86D5325F

P433

Q36184367-7952FE7C-BBD1-452D-9BD5-A221490EC02B

P478

Q36184367-E7178925-63FE-4DD5-B3A3-E73F86986C46

P50

Q36184367-1F4D5D4B-976F-427F-A45D-49A0ECB6931E

P577

Q36184367-8E0AEF4F-A8E0-4325-8565-10202052DB29

P5875

Q36184367-4E0BB5B4-1595-4A89-A0E6-E0A6C0ABC21A

P698

Q36184367-EEAEB0F3-10B5-4BC4-87F4-2C786D7DA081

P932

Q36184367-99F44582-8324-4A47-B123-4CF654BDA5F1

P356

P1433

Human Vaccines & Immunotherapeutics

P1476

Glycoconjugate vaccine strategies for protection against invasive Salmonella infections.

@en

P2093

Raphael Simon

http://www.w3.org/2001/XMLSchema#string

P2860

The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children

Role of monoclonal O-antigen antibody epitope specificity and isotype in protection against experimental mouse typhoid

Incidence of typhoid bacteremia in infants and young children in southern coastal Pakistan

Safety, immunogenicity and dose ranging of a new Vi-CRM₁₉₇ conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults

Efficacious recombinant influenza vaccines produced by high yield bacterial expression: a solution to global pandemic and seasonal needs.

Characterisation of community acquired non-typhoidal Salmonella from bacteraemia and diarrhoeal infections in children admitted to hospital in Nairobi, Kenya.

Identification by PCR of non-typhoidal Salmonella enterica serovars associated with invasive infections among febrile patients in Mali.

Physical and chemical characterization and immunologic properties of Salmonella enterica serovar typhi capsular polysaccharide-diphtheria toxoid conjugates

Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in Africans

Occult bacteremia in young febrile children.

P304

494-498

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/HV.19158

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Myron M. Levine

P577

2012-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221866706

http://www.w3.org/2001/XMLSchema#string

P698

22370510

http://www.w3.org/2001/XMLSchema#string

P932

3426074

http://www.w3.org/2001/XMLSchema#string